Aadi Bioscience rockets 72 percent on key updates

AADI Stock  USD 2.88  0.01  0.35%   
Under 53% of Aadi Bioscience's investor base is interested to short. The analysis of overall sentiment of trading Aadi Bioscience stock suggests that many investors are impartial at this time. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
  
Aadi Bioscience secures exclusive license agreement for Three-Asset ADC Portfolio and sells FYARRO for 100M, raising funds for operations.

Read at seekingalpha.com
seekingalpha News
  

Aadi Bioscience Fundamental Analysis

We analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Aadi Bioscience is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Aadi Bioscience Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aadi Bioscience stock to make a market-neutral strategy. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics with similar companies.

Peers

Aadi Bioscience Related Equities

ACRVAcrivon Therapeutics,   4.32   
0%
100.0%
ANEBAnebulo Pharmaceuticals   3.25   
0%
75.0%
ERASErasca   2.17   
0%
50.0%
GLUEMonte Rosa   1.86   
0%
43.0%
AVTEAerovate Therapeutics   1.55   
0%
35.0%
RZLTRezolute   0.77   
0%
17.0%
ARVNArvinas   0.45   
0%
10.0%
CRNXCrinetics Pharmaceuticals   0.20   
0%
4.0%
RVMDRevolution Medicines   0.46   
10.0%
0%
MLYSMineralys Therapeutics,   0.58   
13.0%
0%
KURAKura Oncology   0.62   
14.0%
0%
ANTXAN2 Therapeutics   0.85   
19.0%
0%
ADAGAdagene   1.07   
24.0%
0%
RAREUltragenyx   1.31   
30.0%
0%
DSGNDesign Therapeutics   2.63   
60.0%
0%
ANABAnaptysBio   3.44   
79.0%
0%

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance